Skip to content
Screener

Liquidia Corporation LQDA Cash & Equivalents

Cash & Equivalents at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
$2.17B-17.3%
Mannkind logo
MannkindMNKD
$52.93M-7.2%
United Therapeutics logo
United TherapeuticsUTHR
$1.8B+13.2%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$262.68M+39.4%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$288.1M+160%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$882.02M+62.5%

Other financials

Income statement

See full
Revenue$132.9M+4,158%
Gross profit$1.6M+6.5%
Operating income$61.5M+274%
Net income$52.9M+238%
EPS (diluted)$0.52+216%

Balance sheet

See full
Total debt$7.0M+1.5%
Total equity$108.6M+118%
Total assets$401.5M+76.6%

Cash flow

See full
Operating cash flow$53.0M+273%
CapEx$2.8M+758%
Free cash flow$50.2M+262%

Valuation

See full
Market cap$7.93B+356%
Enterprise value$7.71B+391%
P/S27.5×-62.3×

Profitability

See full
Gross margin58.1%-18.7pp
Operating margin-155%-68.1pp
Net margin-176.2%-76.4pp
FCF margin-150.7%-64.4pp

Returns & leverage

See full
Return on equity-181%+57.4pp
Debt / equity0.1×-0.1×
Current ratio2.2×-0.7×

Where this comes from

Reported directly by Liquidia Corporation in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The source filing: Liquidia Corporation’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 7:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-058252
Line itemMarch 31, 2026December 31, 2025
Assets
Current assets:
Cash and cash equivalents$222,786$190,680
Accounts receivable, net74,15754,093
Inventory28,50623,802
Prepaid expenses and other current assets7,6064,826
Total current assets333,055273,401
Property, plant and equipment, net20,83811,844

Item 1. Condensed Financial Statements (unaudited)

FAQ

What is Liquidia Corporation's cash & equivalents?
Liquidia Corporation (LQDA) reported cash & equivalents of $222.79M in Q1 2026.
How has Liquidia Corporation's cash & equivalents changed year-over-year?
Liquidia Corporation's cash & equivalents increased by 31.2% year-over-year, from $169.76M to $222.79M.
What is the long-term trend for Liquidia Corporation's cash & equivalents?
Over 5 years (2020 to 2025), Liquidia Corporation's cash & equivalents has grown at a 23.9% compound annual growth rate (CAGR), from $65.32M to $190.68M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Ask your AI about Liquidia Corporation's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude